drugset / Trial / NCT00381368
Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to determine the efficacy and safety of a three time repeated loading dose of intravenous ibandronate (ibandronic acid), 6 mg, in breast cancer patients with painful skeletal metastases.
Timeline
- Start
- 2006-10
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ibandronic acid | Unknown | 6 mg | Intravenous |